| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.057 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.063 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |